FMP

FMP

Enter

OCX - OncoCyte Corporation

photo-url-https://images.financialmodelingprep.com/symbol/OCX.png

OncoCyte Corporation

OCX

NASDAQ

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

2.08 USD

-0.04 (-1.92%)

About

ceo

Mr. Joshua Riggs

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

CIK

0001642380

ISIN

US68235C2061

CUSIP

68235C107

Address

15 Cushing

Phone

949 409 7600

Country

US

Employee

43

IPO Date

Dec 30, 2015

Key Executives

Name

Title

Pay

Year Born

Ms. Sandra O'Donald

Senior Vice President of Business Operat...

0

N/A

Dr. Michael D. West Ph.D.

Scientific Advisor, Co-Chief Executive O...

0

1953

Dr. Paul R. Billings FACP, M.D.

Consulting Chief Medical Officer

0

1952

Mr. Joshua Riggs

President, Chief Executive Officer & Dir...

504.63k

1983

Mr. James Liu

Senior Director, Controller & Principal ...

259.83k

1996

Ms. Andrea Susan James

Chief Financial Officer

0

N/A

Mr. Yuh-Min Chiang Ph.D.

Chief Technology Officer

0

N/A

Mr. Peter Hong

Vice President, General Counsel & Secret...

0

N/A

Dr. Ekkehard Schutz M.D., Ph.D.

Chief Science Officer

409.27k

N/A

As of December 31, 2024, the total employee count stands at 43, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep